Research & Education

Chemotherapy helps elderly patients with small cell lung cancer

Treatment associated with 6-month improvement, even in patients older than 80

DENVER – Although numerous randomized clinical trials have demonstrated a benefit of chemotherapy for patients with small-cell lung cancer (SCLC),

Canadian group gives guideline recommendations for lung cancer screening

Evidence-based recommendations available in October issue of JTO

DENVER – Lung cancer is the most common cause of cancer death in Ontario.

Effect of obesity on patients with advanced non-small cell lung cancer

Researchers find superior outcomes initially, but worse overall

DENVER – Obesity increases health risks for many things.

Researchers find potential new target to treat malignant pleural mesothelioma

Study describes overexpression of Ephrin B2 in cell lines and tumors

DENVER – Malignant mesothelioma is a rare asbestos-associated malignancy with limited therapeutic options.

Need for national Canadian strategy for EGFR testing

Testing dropped once funding from pharmaceutical industry was discontinued

DENVER – Significant advances have taken place in the management of patients with advanced and metastatic non–small-cell lung cancer (NSCLC) over t

CAP IASLC AMP Molecular Testing Guideline

Leading Health Care Organizations issue Guideline recommendations for Molecular Testing and Targeted Therapies

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular P

Pages